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Recent studies have shown that neurodegeneration is closely related to misfolding and aggregation of neuronal tau. Our
previous results show that neuronal tau aggregates in formaldehyde solution and that aggregated tau induces apoptosis of
SH-SY5Y and hippocampal cells. In the present study, based on atomic force microscopy (AFM) observation, we have found
that formaldehyde at low concentrations induces tau polymerization whilst acetaldehyde does not. Neuronal tau misfolds and
aggregates into globular-like polymers in 0.01–0.1% formaldehyde solutions. Apart from globular-like aggregation, no fibril-
like polymerization was observed when the protein was incubated with formaldehyde for 15 days. SDS-PAGE results also
exhibit tau polymerizing in the presence of formaldehyde. Under the same experimental conditions, polymerization of bovine
serum albumin (BSA) or a-synuclein was not markedly detected. Kinetic study shows that tau significantly misfolds and
polymerizes in 60 minutes in 0.1% formaldehyde solution. However, presence of 10% methanol prevents protein tau from
polymerization. This suggests that formaldehyde polymerization is involved in tau aggregation. Such aggregation process is
probably linked to the tau’s special ‘‘worm-like’’ structure, which leaves the e-amino groups of Lys and thiol groups of Cys
exposed to the exterior. Such a structure can easily bond to formaldehyde molecules in vitro and in vivo. Polymerizing of
formaldehyde itself results in aggregation of protein tau. Immunocytochemistry and thioflavin S staining of both endogenous
and exogenous tau in the presence of formaldehyde at low concentrations in the cell culture have shown that formaldehyde
can induce tau into amyloid-like aggregates in vivo during apoptosis. The significant protein tau aggregation induced by
formaldehyde and the severe toxicity of the aggregated tau to neural cells may suggest that toxicity of methanol and
formaldehyde ingestion is related to tau misfolding and aggregation.
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INTRODUCTION
Neuronal tau is an important protein in promoting and stabilizing
the microtubule system involved in cellular transport and neuronal
morphogenesis. The tau molecule can be subdivided into an
amino-terminal domain that projects from the microtubule surface
and a carboxy-terminal microtubule-binding domain. The dis-
covery that incubation of bacterially expressed human tau with
sulphated glycosaminoglycans leads to bulk assembly of tau
filaments [1], making it possible to obtain structural information
[2]. By using circular dichroism measurement, Schweer et al. have
found that protein tau lacks secondary structures and is considered
in a ‘‘worm-like’’ conformation with a high flexibility [3].
Therefore, the side-chains of amino acids such as Lys, Cys, Thr
and Ser are mostly exposed and vulnerable to chemical modifi-
cation. Recently, many laboratories have found that misfolding
and aggregation of protein tau are involved in neurodegeneration
[2,4–6]. Protein tau has been found as the major component of
paired helical filaments in neurofibrillary tangles in the brains of
Alzheimer’s patients, where abnormal hyper-phosphorylation
induces tau to misfold and form the paired helical filaments,
depositing in the cytoplasm of neurons [7–10].
Recently, a great deal of evidence has demonstrated that
oxidation and glycation stresses are key causal factors of neuronal
degenerative diseases [11–13]. Both of them inevitably produce
a variety of unsaturated carbonyls as intermediates, like malondial-
dehyde and 4-hydroxynonenal, which usually cause carbonyl-amino
crosslinking and lead to accumulation of irreversible changes (like
lipofuscin) related to various neurodegenerative diseasesin particular
[14–16]. Such carbonyl stress-related reactions (carbonylation) can
form unstable and reversible 1:1 amino-carbonyl (Shiff’s base)
compounds at an early stage of protein modification [16,17].
Carbonylation binds and blocks a-/e- amino groups, and results in
changes in charge and conformation of a protein. In order to
investigate the relationship between carbonylation and protein tau
misfolding,thebasicand simplestcarbonylcompoundformaldehyde
[18] has come into our attentions.
Formaldehyde is a common environmental agent found in paint,
cloth, exhaust gas and many other medicinal and industrial products
[19]. Formaldehyde exposure leads to formation of DNA/protein
crosslinks, a major mechanism of DNA damage. The DNA/protein
crosslinks have been used as a measure of dose in drug delivery [20].
Formaldehyde, as a crosslinking agent, also reacts with thiol and
amino groups, leading to protein polymerization [21,22]. Further-
more, methanol ingestion is an important public health concern
because of the selective actions of its toxic metabolites, formaldehyde
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Figure 1. AFM Images of neuronal tau in the presence of formaldehyde at different concentrations. Neuronal tau (20 mM) was incubated in
50 mM phosphate buffer (pH 7.2) containing formaldehyde at different concentrations as indicated at 37uC over night (A–E). Aliquots were taken and
diluted to the desired concentration using the phosphate buffer, and the samples were dropped onto mica surfaces and dried in air before observed
under the atomic force microscope. The frequency counts of the horizontal diameters (explained in the text) of the protein particles in images A–E
were shown in A’–E’, respectively. The scale bars equal 100 nm.
doi:10.1371/journal.pone.0000629.g001
Globular Amyloid-Like tau
PLoS ONE | www.plosone.org 2 July 2007 | Issue 7 | e629and formic acid, on the retina, the optic nerves and the central
nervous system (CNS) [23]. Illicit consumption of industrial
methylated spirits can cause severe and even fatal illness [24]. In
the liver and retina, methanol is oxidized by alcohol dehydrogenase,
resulting in formaldehyde. In semicarbazide-sensitive amine oxidase
(SSAO)-mediated pathogenesis of Alzheimer’s disease, formalde-
hydeinteractswithb-amyloidsandproducesirreversiblycross-linked
neurotoxic amyloid-like complexes [21,22,25].
We have examined the role of formaldehyde in misfolding of
protein tau [26]. In particular, we investigated the toxicity of
formaldehyde-induced tau aggregates on human neuroblastoma
cells (SH-SY5Y cell line) and rat hippocampal cells [27]. The results
showed that low concentrations (0.01–0.1%) of formaldehyde are
sufficient to induce formation of amyloid-like tau aggregates, which
can induce apoptosis of both SH-SY5Y and hippocampal cells. This
may be significant to understand the mechanism of chronic damage
caused by methanol toxicity and formaldehyde stress [18,28].
However, we have still not known the mechanism of protein tau
aggregation in the presence of formaldehyde at low concentrations.
The present study concerns the characteristic of misfolding and
polymerization of extracellular and intracellular neuronal tau
induced by formaldehyde at low concentrations.
RESULTS
Changes in size of tau aggregates at different
concentrations of formaldehyde
AFM observation of native and formaldehyde-treated neuronal
tau is presented in Figure 1. All images were obtained in air.
Both native and formaldehyde-treated tau appeared as globular
particles but of different sizes. Native tau showed globules with
diameter of approximately 962 nm (Figure 1A). The diameter
increased significantly in the presence of formaldehyde, to
1863 nm when tau was incubated in the presence of only
0.05% formaldehyde (Figure 1D), about twice of that of native tau.
The diameter increased following the increase of formaldehyde
concentration (Figure 1B–E). Histograms presented in Figures 1A’
through to E’ showed particle diameter distributions in the
presence of formaldehyde at different concentrations. The data
indicate that the presence of formaldehyde, even at very low
concentrations, results in polymerization of protein tau. For
a better visual effect to show the particle size difference, the AFM
images of native and 0.1% formaldehyde-treated tau were also
presented in a ‘‘three-dimensional’’ fashion in Figure 2A and B. It
is also worthwhile to mention that no fibrils were ever observed in
spite of the particle size increase in the presence of formaldehyde.
Though the polymerization of tau was easily observed in the
presence of formaldehyde (Figure 2C), as a control, no significant
polymerization of BSA was observed under the same conditions
(Figure 2D). This suggests that the conformation of neuronal tau is
more sensitive to formaldehyde than that of BSA.
To control the AFM observation, neuronal tau incubated with
different concentrations of formaldehyde was electrophoresed on
SDS-PAGE (Figure S1A). Existence of tau polymers was detected
on the PAGE following the increase of formaldehyde concentra-
tion. Measurement of gray density of the protein bands on the
SDS-PAGE (Figure S1B) exhibits a noticeable increase of tau
polymers and a corresponding decrease of tau monomers in the
same range of formaldehyde concentration as observed in AFM
experiments.
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Figure 2. Three-dimensional images and horizontal diameters of tau at different concentrations of formaldehyde. The data using for
regenerating three-dimensional images of neuronal tau in the presence (A) and absence (B) of formaldehyde solution (0.1%) are the same used for
Figures 1A and E. Change in the horizontal diameter of the tau protein particles on mica surface at different concentrations of formaldehyde is
depicted in C. Change in the horizontal diameter of BSA was used as control (D).
doi:10.1371/journal.pone.0000629.g002
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was detected by SDS-PAGE when acetaldehyde, instead of
formaldehyde, was used under the same conditions (Figure S1C
and S1D). This result was further supported by AFM observation,
where a constant particle diameter of about 10 nm was observed
when acetaldehyde concentration was changed from 0.1% to 1%
under the same conditions (Figure S2).
Glutaraldehyde (0.01–1%) was used as a positive control. The
AFM images were not shown but the mean values of particle
diameters at different glutaraldehyde concentrations are presented
in Figure S3. The results showed that both neuronal tau and
BSA were polymerized in the presence of glutaraldehyde under
the same conditions. The diameters of observed particles for
tau and BSA were 9.261.2 nm and 17.562.4 nm, respectively,
in the absence of glutaraldehyde whilst 21.8362.67 nm and
37.2263.57 nm, respectively, in the presence of glutaraldehyde.
Kinetic course of tau aggregation in formaldehyde
solution
To investigate the kinetics of tau aggregation in the presence of low-
concentration formaldehyde, neuronal protein tau was incubated in
0.1% formaldehyde and aliquots were taken for AFM observation at
different time intervals. The AFM images were shown in Figure 3A–
G whilst the corresponding particle diameter distributions were
shown in Figure 4A–G. The results showed a rapid start (within
10 min) of aggregation in the presence of formaldehyde and
a remarkable increase of particle size in about 60–120 min. Parallel
SDS-PAGE measurements also revealed a similar time evolution
(Figure 3H). The kinetic change in the size of aggregates showed
a rapid polymerization of tau during the first 60 min (Figure 4H).
Analysis of the polymerizing kinetics with Tsou’s method [29]
showed a linear procedure for tau polymerization in the presence of
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Figure 3. Kinetic aggregation of tau in formaldehyde solutions. Neuronal tau was added to the phosphate buffer (pH 7.2, 37uC) containing 0.1%
formaldehyde, and aliquots were taken for observation under the atomic force microscope at different time intervals as indicated in each images (A–
G). The scale bars equal 100 nm. The parallel SDS-PAGE study (H) shows tau incubated with 0.1% formaldehyde for different time periods, with Lanes
1 to 8 representing 0, 30, 60, 90, 120, 150, 180 and 240 min, respectively. Lane M is the protein molecular mass marker. Acetaldehyde (0.1%) was used
as a control and the result is shown in I.
doi:10.1371/journal.pone.0000629.g003
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24 s
21.
As a control, no aggregation was detected by SDS-PAGE in the
same time course when acetaldehyde, instead of formaldehyde, was
added to the tau solution (Figure 3I).
Furthermore, to confirm that formaldehyde induces tau into
globular aggregates, we had incubated protein tau with 0.1%
formaldehyde for 15 days, and then observed the aggregation
under AFM. As shown in Figure 5, the polymer of tau was still in
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Figure 4. Changes in horizontal diameters of tau at different time intervals in 0.1% formaldehyde solution. The frequency counts of the
horizontal diameters of tau protein at different incubation time (A–G) are based on the AFM images shown in Figures 3A–G, respectively. The mean
values are summarized in H.
doi:10.1371/journal.pone.0000629.g004
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experimental conditions.
It is known that formaldehyde reacts with the side chain of
amino acid residues containing e-amino and thiol groups [21].
Tau-40 contains 44 lysine and 2 cysteine residues (NP_005901)
[1,30], which should react with formaldehyde. 5,59-Dithio-bis(2-
nitrobenzoic acid) (DTNB) modification was used to check the
thiol groups of tau incubated under different concentrations of
formaldehyde (Figure 6) whilst o-phthaldehyde (OPT) modification
was used to detect the amino groups of tau under the same
conditions as described previously [27]. Both DTNB absorbance
(412 nm) and OPT fluorescence (Em 455 nm/Ex 340 nm) de-
creased following the increase of formaldehyde concentration. In
kinetic study, as shown in Table 1, the first order rate constants of
DTNB and OPT reacting with formaldehyde-treated tau were
much lower than those with native tau. This indicates that both
thiol and amino groups of tau were blocked in the presence of
formaldehyde.
To confirm the contribution of thiol groups to tau aggregation,
a-synuclein, which does not contain any thiol group (NP_000336),
was employed in this work. As shown in Figure 7B, polymerizaion
of a-synuclein could hardly be observed in SDS-PAGE when
formaldehyde concentration was less than 1% (though the
monomer slightly decreased in the solutions). This indicates that
a-synuclein is less vulnerable to the induction of the aldehyde than
protein tau (Figure 7A). On the other hand, ribonuclease A
(RNase A) contains 4 disulfide bridges which can be reduced by
dithiothreitol (DTT) [31]. The oligomer of reduced RNase A
increased observably in the presence of 0.01% formaldehyde
(Figure 7C). The intact RNase A, however, started to aggregate
when formaldehyde concentration increased to 0.3% (Figure 7D)
under the same conditions.
Formaldehyde self-polymerization and tau
aggregation
According to Pomerantz et al. [32], formaldehyde polymerizes
itself in water whilst 10–15% methanol can prevent such
polymerization. To investigate the methanol effect, we did AFM
experiments of tau with existence of 0.1% formaldehyde
(Figure 8A), 10% methanol (Figure 8C) and mixture of 0.1%
formaldehyde with 10% methanol (Figure 8B), in comparison with
the native tau (Figure 8D). The mean values of observed particle
diameters in the four cases are illustrated in Figure 8E, which
showed that as long as methanol is present (Figure 8B and C), the
particle sizes were similar to that of native tau (about 10 nm in
diameter). This indicates that no aggregation occurs in the
presence of methanol, even with existence of formaldehyde. Only
in the presence of formaldehyde alone, aggregation with a diameter
of about 2267 nm was observed. This suggests that formaldehyde
self-polymerization plays an important role in tau aggregation and
polymerization. If formaldehyde polymerization was blocked, as in
the present case, by methanol, no further aggregation of tau would
occur.
Low concentration of formaldehyde inducing
endogenous tau to aggregate
Our previous results showed that extracellular tau aggregates were
toxic to neuronal cells [27]. We detected intracellular tau aggrega-
tion by formaldehyde in cell apoptosis. According to Khlistunova
et al. [33], tau expression was judged by fluorescence microscopy
with monoclonal antibody Tau-1. In the present study, we probed
the same cells using a dye thioflavin S (ThS), which characteris-
tically fluoresced when amyloid structures with a high content of
cross-b-structures were formed [34]. ThS fluorescence is a faithful
marker of the aggregation of tau and its derivatives in vitro.
Formaldehyde-treated cells displayed a strong reaction with ThS,
while untreated cells did not show any signals in such a reaction.
This indicates that formaldehyde induces amyloid-like aggregates
in the cells. Furthermore, an overlapping of both Tau-1 and ThS
signals in the cytoplasm suggests that protein tau is induced to
form amyloid-like aggregates in the presence of formaldehyde
(Figure 9). Importantly, tau aggregation preceded nuclear
condensation and fragmentation after incubation in the presence
of 0.0005% formaldehyde for 3 days. This shows that formalde-
hyde could induce intracellular tau to aggregate.
To demonstrate tau is aggregated in a cell and such aggregation
is related to apoptosis, we transfected HA-tau into HEK 293 cells
(Figure 10A). Note that the HEK 293 cells do not express protein
tau [35]. After treated with 0.0002% formaldehyde for 72 h, tau
aggregation was detectable in the transfected 293 cells by
westernblotting (Figure 10B). Immunostaining remarkably visual-
ized amyloid-like tau aggregation in the cells (Figure 10C). At the
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Figure 5. Aggregates of tau incubated in 0.1% formaldehyde for 15 days. The experimental conditions were described in Figure 3, except that the
incubation time was prolonged to 15 days. A typical AFM image of tau in the presence of formaldehyde is present in A (Bar: 100 nm), together with
a three dimensional image (B) for a better visual effect. Frequency counts of horizontal diameters of particles are presented in C.
doi:10.1371/journal.pone.0000629.g005
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that of the control cells (Figure 10D). The cells transfected with
control vectors showed no aggregates and apoptosis. This suggests
that formaldehyde at low concentration induces amyloid-like tau
aggregates in the cells, which are related to apoptosis.
In conclusion, our data are well consistent with a mechanism in
which formaldehyde first reacts with the thiol and amino groups of
tau, and then self-polymerizes to integrate tau proteins to form the
amyloid-like aggregates (Figure 11). Conceptually, formaldehyde
behaves like a crosslinker to bond the formaldehyde-modified tau
molecules in vitro or in vivo.
DISCUSSION
Clinical lethal dose of formaldehyde
Why did we investigate tau misfolding in the presence of
formaldehyde at low concentrations (0.01–0.1%)? Methanol and
ethanol are metabolized to formaldehyde and acetaldehyde re-
spectively in our hepatocytes and some neural cells [36,37]. Both
formaldehyde and acetaldehyde can go through the blood-brain
barrier and cause some lesions to CNS, especially our visual system
[38]. Clinically, the lethal dose of formaldehyde for human beings is
about 0.08% in the circulation [39]. We have shown in the present
study that formaldehyde can significantly induce tau aggregation
and polymerization at concentrations even lower than 0.08%, the
clinical dose of toxicosis. The same low concentration of formalde-
hyde did not induce polymerization of BSA though theoretically it
will cause any protein to polymerize if the concentration is high
enough. On the other hand, although it is known that acetaldehyde
is acutely toxic and would covalently bind to proteins and other
macromolecules [40], in our AFM and SDS-PAGE studies we did
not observe tau polymerization caused by acetaldehyde at the
concentration range that we studied (0.1–1%).
Measurement of tau aggregate size in AFM
observation
In the presence of formaldehyde at low concentrations (0.01–
0.1%), globular aggregates of neuronal tau were observed in AFM
when the samples were deposited on mica surfaces and dried in
air, indicated by an increase of the lateral dimension of the
globular particles following the increase of formaldehyde concen-
trations. Usually, both lateral dimension and height should be
considered in particle size analysis. In the present work, we used
the lateral dimension, and furthermore the ‘‘horizontal diameter’’,
to assess the protein polymerization. This is based on consider-
ation of the molecular conformation. Neuronal tau is in a worm-
like conformation, a native denatured state. Thus when polymer-
ized and attached to the mica surface, the change in height may
not be significant whilst the change in lateral dimension will be
relatively easier to measure. To quantify the lateral dimension, we
follow the statistical ‘‘horizontal diameter’’ method [41,42]. In this
method, the diameters of particles along each of the horizontal
scan lines (or the ‘‘fast scan axis’’, as called in the NanoScope
AFM) are measured. All particles in the image are measured
without any discrimination. In such a way, the statistic result of the
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Figure 6. Reaction of formaldehyde with thiol groups of neuronal
tau. Neuronal tau (2 mM) was re-suspended in phosphate buffer
containing DTNB (20 times in excess to the protein in molar ratio) in the
presence of formaldehyde at different concentrations at 37uC for
120 min. The DTNB absorbance (A, 412 nm) was measured. Under the
same conditions, native tau (Curve 1) and 0.005% formaldehyde-treated
tau (Curve 2) were re-suspended in 2 mM DTNB (B), and aliquots were
taken to measure the absorbance at different time intervals. The same
data shown in B are also plotted in semilogarithm (C) according to
Tsou’s method [29].
doi:10.1371/journal.pone.0000629.g006
Table 1. The first order rate constants of DTNB and OPT
reacting with native tau and 0.005% formaldehyde-treated
tau.
......................................................................
In the presence of DTNB In the presence of OPT
Native tau
Formaldehyde-
treated tau Native tau
Formaldehyde-
treated tau
Fast phase 130.267.01 43.563.01 81.366.13 7.760.91
Slow phase 23.463.42 5.660.87 32.162.05 7.460.79
Data are in 10
5 s
21.
doi:10.1371/journal.pone.0000629.t001
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average lateral size. Another advantage of this method is that it
can avoid errors in lateral dimension measurement caused by
possible image distortion caused by thermal drift, a typical
instrumental artifact in scanning probe microscopy. To further
guarantee the credibility, for each formaldehyde concentration
that we studied, several images were used so that at least 100
particles in total were measured for each concentration.
It should be noticed that the AFM tip-broadening effect was not
considered in our measurement. So, the horizontal diameter
values might be overestimated. However, the most important
thing is to guarantee the broadening effect is constant for compar-
ison study. For such consideration, we always used the images
obtained with the same AFM tip for quantitative analysis
whenever a comparison was required.
A putative mechanism of tau aggregation in
formaldehyde solution
Formaldehyde reacts with a-/e-amino groups and thiol groups.
On the other hand, formaldehyde polymerizes itself in water [32],
and the experiment shows that 10–15% methanol prevents tau
polymerization. This suggests that tau aggregation may be due to
the formaldehyde polymerization, which causes cross-linking
between tau protein molecules. As shown in Figure 11, a tau
monomer first reacts with a formaldehyde molecule, followed by
more formaldehyde molecules polymerized and assembled onto
the protein molecules. Finally, tau molecules are cross-linked by
polymerized formaldehyde. Such a link could not be separated
even on SDS-PAGE (Figure S1A and Figures 3H and 7A).
However, the mechanism of tau aggregation in vivo needs to be
further investigated.
Difference between tau and control proteins in
reaction to the presence of crosslinkers
Our present study showed that tau aggregated in the presence of
low concentration formaldehyde whilst BSA and a-synuclein did
not markedly. According to the previous studies [3], the conforma-
tion of native tau features a ‘‘worm-like’’ or a ‘‘denatured-like’’
structure, leaving e-amino groups of Lys and thiol groups of Cys
exposed to the exterior of the tau molecule. Thus, formaldehyde
can easily bind with these side groups. For crosslinking of globular
proteins, formaldehyde is not as efficient as the commonly used
glutaraldehyde. Glutaraldehyde is capable of directly cross-linking
two protein molecules and binds the bilateral amino groups. On
the other hand, BSA is a well-folded globular protein with limited
e-amino groups exposed, and hence relatively stable under low
concentration of formaldehyde. Although a-synuclein is unstruc-
tured and has the propensity to form amyloid-like aggregates [43],
this protein does not contain any Cys residues. The lack of Cys
residue may be a reason for a-synuclein to show a little aggregation
in the presence of formaldehyde (1%). Furthermore, RNase A is
a single chain polypeptide containing 4 disulfide bridges [44].
Previous gel electrophoresis study has showed that formaldehyde
treatment of RNase A leads to a rapid formation of protein cross-
links [45,46]. Thus, RNase A was used as a positive control in our
experiments. The DTT-treated RNase A is prone to form
aggregation (Figure 7C and D). This indicates that thiol groups
are involved in protein polymerization under the induction of
formaldehyde. Protein tau consists of two thiol groups, Cys-291
and Cys-322 (NP_005901). The fact that neuronal tau is prone to
aggregate at low concentration of formaldehyde probably reflects
the special characteristics of its native conformation.
It is necessary to indicate that all proteins should be aggregated
in the presence of formaldehyde if the aldehyde concentration is
high enough. Different proteins require different minimum
formaldehyde concentrations to induce aggregation. In compar-
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Figure 7. Formaldehyde-treated a-synuclein and RNase A on SDS-
PAGE. Protein tau (A)o ra-synuclein (amino acid sequence referred to
NP_000336) (B) was incubated in 100 mM phosphate buffer (pH 7.2)
containing formaldehyde at different concentrations as indicated at
37uC over night, and then aliquots were taken for SDS-PAGE. RNase A
(3 mg/ml) was pretreated with DTT (10 mM) in 100 mM phosphate
buffer (pH 7.2) at 37uC for 1 h and dialysed at 4uC over night as
described [31]. The dialysed RNase A (10 mg) was incubated with
formaldehyde at different concentrations as indicated at 37uC for 4 h
(C). Aliquots were then taken for SDS-PAGE. RNase A incubated without
DTT was used as control (D).
doi:10.1371/journal.pone.0000629.g007
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formaldehyde.
Tau aggregation relating to methanol and
formaldehyde toxicity
Methanol is an ocular toxicant, which causes visual dysfunction
and often leads to blindness after acute exposure. However,
physiological and biochemical changes responsible for the toxicity
have not yet been well understood [28]. According to a recent
report, humans are uniquely sensitive to the toxicity of methanol,
as they have limited capacity to oxidize and detoxify formic acid.
Thus, the toxicity of methanol in humans is characterized by
formic acidaemia, metabolic acidosis, blindness or serious visual
impairment, mild central nervous system depression and even
death [23,27,28]. However, methanol toxicosis induces progressive
complications to CNS. It is hard to explain the progressively
chronic damage by local accumulation of formic acid alone.
Therefore, the potential effect of formaldehyde on protein
misfolding may be significant, although formaldehyde remains in
the human body for only a short time. In semicarbazide-sensitive
amine oxidase (SSAO)-mediate pathogenesis of Alzheimer’s
disease, formaldehyde interacts with b-amyloids and produces
irreversibly cross-linked neurotoxic amyloid-like complexes
[21,22,25]. Our studies showed that formaldehyde induced
neuronal tau to aggregate. The amyloid-like tau induces apoptosis
of SY5Y and hippocampal cells [27]. In fact, chemically,
formaldehyde reacts with thiol and amino groups instantly,
resulting in subsequent misfolding of neuronal tau (Figure 11).
This suggests that amyloid-like tau is involved in methanol
toxicosis, especially the damage of neurons and the resulted
complications after exposure to formaldehyde.
Although there have been many studies on methanol and
formaldehyde intoxication [23,24], none of them has addressed
the contribution of protein misfolding to the pathological
mechanism, in particular the effect of formaldehyde on protein
conformation and polymerization. Interestingly, neurofibrillary
tangles have been found in brains of chronic alcoholics possessing
neuropathological signs of thiamine-deficiency [40,47]. This
suggests that tau misfolding may be involved in the alcohol-
induced pathological pathway. Khlistunova and his colleagues
found that neuronal tau repeat domain could aggregate in vivo and
was toxic to neuronal cells. The degree of tau aggregation and
toxicity depends on the propensity of the b-structure [2,48]. In the
present study, we have demonstrated that amyloid-like intracel-
lular tau aggregates could induce cell apoptosis, a similar result as
that obtained for extracellular amyloid or a-synuclein [49–51].
This suggests that an enriched b-sheet structure is important to
amyloid-like protein aggregation and neurotoxicity. In our
experiments, a low concentration of formaldehyde induced both
extracellular and intracellular tau proteins to aggregate into cell-
toxic amyloid-like granular aggregates [27]. It appears to provide
a new mechanism for triggers of tauopathies in the formaldehyde
toxicosis.
MATERIALS AND METHODS
Expression and purification of recombinant htau-40
The clone of recombinant human tau-40 was kindly provided by
Dr. Goedert (University of Cambridge, UK) [9]. Protein tau,
overexpressed in E. coli, was purified as described previously
[52,53]. The bacterial cells were homogenized with a sonicator,
boiled at 100uC for 15 min and the protein was purified using
Sepharose-Q, Sepharose-SP and Sephadex-50 chromatography
columns (Pharmacia, USA). The concentration of recombinant
tau was determined with a spectrophotometer (Hitachi U-2010,
Japan) by measuring the absorbance at 280 nm [54]. Tau-40
appeared as a single band in SDS-PAGE after purification. Assay
of tau was performed in the promotion of tubulin assembly
following the Alonso’s method [8]. Porcine brain tubulin was
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Figure 8. Effect of 10% methanol on neuronal tau aggregation. Conditions were referred to Figure 1, except that additional methanol was used to
disturb the reaction of formaldehyde with neuronal tau. The images show neuronal tau incubated in phosphate buffer in the presence of 0.1%
formaldehyde only (A); mixture of 10% methanol and 0.1% formaldehyde (B); 10% methanol only (C); and tau alone (D). The scale bars equal 100 nm.
The corresponding horizontal diameters are summarized in E.
doi:10.1371/journal.pone.0000629.g008
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was the same as that described by Goedert [1].
Tau aggregation in the presence of aldehyde
Neuronal tau with additions of different concentrations of
formaldehyde (Sigma, USA) or acetaldehyde (ACROS Organic,
USA) in 50 mM phosphate buffer (pH 7.2) at final tau concentra-
tion of 10–20 mM was incubated at 37uC overnight to allow the
reaction to reach completion. The concentration of aldehyde-
aggregated tau used was 10–20 mM according to the report that
endogenous tau is present at 5–10 mM in human brain [55]. Then
protein solution was diluted to the desired concentration using the
phosphate buffer and 3 ml of the sample was deposited onto a mica
surface and kept for 5 min at room temperature. The mica was
rinsed with ultra-purified water 20 times and thoroughly dried
with nitrogen gas before being observed by AFM. Glutaraldehyde
(ICN Biomedicals Inc, USA) and BSA (Sigma, USA) were used as
controls. For time-lapse analyses, aliquots were taken at different
time intervals while tau was incubated with formaldehyde or
acetaldehyde. Then the sample was observed under AFM or
loaded onto 10% SDS-PAGE. To test whether tau polymerization
is related to formaldehyde polymerization, 10% methanol was
added when the tau protein was incubated in the presence of 0.1%
formaldehyde at 37uC overnight. AFM studies were conducted on
a Mutiplemode AFM with a NanoScope IIIa controller (Veeco
Instruments, USA).
DTNB and OPT modification
Neuronal tau was resuspended in 100 mM phosphate buffer
containing OPT (Sigma, USA) or DTNB (Sigma, USA) at a molar
ratio of 20/1 (reagent/protein) in the presence of formaldehyde at
different concentrations at 37uC for 120 min. The absorbance
(412 nm for DTNB modification) was then measured on
a spectrophotometer (Hitachi U-2010, Japan). For OPT modifi-
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Figure 9. Tau aggregation in SY5Y cells in the presence of formaldehyde. SY5Y cells were cultured and incubated with 0.0005% formaldehyde for
72 h. Immunolabelling with the monoclonal antibody Tau-1 was used to visualize tau expression (A) and thioflavin S was to detect tau aggregates in
the cells (B). Cells stained with DAPI showed apoptotic cells with the shrunk nuclei (C). Bar: 50 mm. D–F (magnified from A and B, Bar: 25 mm) show
that the signals of ThS (amyloid-like aggregates) and the monoclonal antibody Tau-1 overlap each other in the cells. Quantitative results of protein
tau aggregation and cell apoptosis are shown in G. Fluorescence intensity of tau aggregation stained by ThS during time course is shown in H.
doi:10.1371/journal.pone.0000629.g009
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(slit=5.0 nm for both Ex and Em) on a fluorescence spectropho-
tometer (Hitachi F-4500, Japan). Under the same conditions, tau
was resuspended in 0.005% formaldehyde and 2 mM DTNB or
2 mM OPT and aliquots were taken to measure the absorbance
and the fluorescence at different time intervals. The data were
analyzed following Tsou’s method [29].
a-Synuclein and RNase A aggregation in the
presence of formaldehyde
The clone of human a-Synuclein (as a gift from Prof. Hong-Yu Hu
in the Institute of Biochemistry and Cell Biology, CAS, Shanghai)
was expressed in E. coli and purified as described [56]. The
purified a-synuclein showed a single protein band on SDS-PAGE.
a-Synuclein was incubated in 100 mM phosphate buffer (pH 7.2)
containing formaldehyde at different concentrations at 37uC over
night, and then aliquots were taken for SDS-PAGE. RNase A
(Sigma, USA) was pretreated with DTT (10 mM) in 100 mM
phosphate buffer (pH 7.2) at 37uC for 1 h and dialysed at 4uC
over night as described [31]. The dialysed RNase A was incubated
with formaldehyde at different concentrations at 37uC for 4 h, and
aliquots were then taken for SDS-PAGE. RNase A incubated
without DTT was used as a control.
Detection of tau aggregation in cells by thioflavin S
SY5Y cells were treated by 0.0005% formaldehyde for 72 h.
Then, the cells on the coverslips were fixed with 4% para-
formaldehyde in PBS for 15 min, permeabilized with 80% MeOH
for 6 min at 220uC, incubated with 0.1% ThS (Sigma, USA) for
5 min, and washed three times in ethanol (50%). The samples were
incubated with antibody Tau-1 (Chemicon, USA) in 5% goat serum
PBS solution. The secondary anti-mouse antibody labeled with TR
(Santa Cruz, USA) was also diluted with 5% goat serum in PBS and
incubated for 45 min. The cells were washed twice with PBS and
once with double-distilled water, and then mounted with Mowiol
media containing DAPI. Cells containing distinct ThS signals to
indicate the presence of the aggregated material with b-pleated
sheets were scored in independent fields containing a total of 300
cells [33]. The fluorescence intensity of tau aggregation stained by
ThS was analyzed with Lsmix software (Zeiss, Germany).
Tau transfection and aggregation in the HEK 293
cells
HEK 293 cells were placed on 6-well tissue plates and transiently
transfected with the appropriate HA-tau (as a gift from Dr. Ya-Jie
Xu in the Institute of Biophysics, CAS) or control plasmid
following the protocol described by the manufacturer. Typically,
Figure 10. Toxicity of tau aggregation to HEK 293 cells in the presence of formaldehyde. HEK 293 cells were cultured and transient with HA-tau or
the control vector, followed by incubation with 0.0002% formaldehyde for 72 h. Immunolabelling with the monoclonal antibody HA was used to
visualize tau expression (A) and tau aggregation in the presence of 0.0002% formaldehyde for different times (B). b-actin was used as a protein
loading control. Immunostaining detected tau aggregation in 293 cells after treated with formaldehyde for 72 h (C, Bar: 25 mm). Other conditions
were similar to SY5Y cells shown in Figure 9. Quantitative analysis is presented in D. Apoptotic cells are characterized by nuclear condensation and
diffraction. At least 200 apoptotic cells were counted in each experiment.
doi:10.1371/journal.pone.0000629.g010
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USA) were used per coverslip. The cells were incubated for 4 h in
the transfection mixture prior to replacement with fresh culture
medium. The transfected cells were visualized by fluorescence
microscopy. After transfection for 24 h, HEK 293 cells were
treated by 0.0002% formaldehyde for 72 h. Part of the cells was
fixed for immunofluorescence, and the others were performed for
immunoblotting [35]. The cells resuspended in NP-40 containing
lysis buffer (10 mM Hepes, pH 7.4, 2 mM EGTA, 0.5% NP-40,
1 mM NaF, 1 mM NaVO4, 1 mM PMSF, 1 mM DTT, 50 mg/
ml trypsin inhibitor, 10 mg/ml aprotinin and leupeptin) and
placed on ice for 30 min. The lysates were centrifuged (12,000 g,
4uC, 12 min) and the protein concentration was determined.
Equivalent samples (100 mg protein) were subjected to SDS-PAGE
on 8% gel. The proteins were then transferred onto nitrocellulose
membranes, and probed with anti-HA (Santa Cruz, USA) or anti
b-actin antibodies (Sigma, USA) followed by the appropriate
secondary antibodies conjugated to horseradish peroxidase (HRP)
(KPL, Gaithersburg, Maryland, USA). Immunoreactive bands
were visualized using enhanced chemiluminescence (Pierce, USA).
The molecular sizes of the developed proteins were determined by
comparison with prestained protein markers (Invitrogen, CA).
SUPPORTING INFORMATION
Figure S1 Formaldehyde-treated tau on SDS-PAGE. Condi-
tions for the incubation of tau with formaldehyde were the same as
those for Figure 1. Desired concentrations of formaldehyde were
used as indicated. Protein tau solution with varied formaldehyde
concentrations was used for each load in 10% SDS-PAGE (A).
The gray densities of the protein bands on SDS-PAGE were
measured (B) Curves 1 and 2 in B represent the densities of tau
polymer and monomer, respectively. As a control, acetaldehyde of
the same concentration range as that of formaldehyde under the
same conditions was used (C), with the gray densities shown in D.
Found at: doi:10.1371/journal.pone.0000629.s001 (0.44 MB EPS)
Figure S2 Neuronal tau incubated with different concentrations
of acetaldehyde observed by AFM. Conditions were referred
to Figure 1, except that the formaldehyde was replaced by
acetaldehyde. The neuronal tau was incubated with acetaldehyde
at 0.1% (A), 0.5% (B) and 1.0% (C) concentrations (Bar: 100 nm).
The mean values of the horizontal diameters of observed tau
particles at different acetaldehyde concentrations are presented
in D.
Found at: doi:10.1371/journal.pone.0000629.s002 (0.82 MB EPS)
Figure S3 Crosslinking of tau in glutaraldehyde solutions at
different concentrations. Conditions are referred to Figure 1,
except that the formaldehyde was replaced by glutaraldehyde as
a positive control. The images are not shown here, but the mean
values of the horizontal diameters of observed neuronal tau (Curve
1) and BSA (Curve 2) particles against the glutaraldehyde
concentration are displayed.
Found at: doi:10.1371/journal.pone.0000629.s003 (0.08 MB EPS)
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